Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
KP.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBL.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.28.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.48.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.50.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
LB.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used